Treatment of Older Patients With Mantle Cell Lymphoma (MCL): Long-Term Follow-Up of the Randomized European MCL Elderly Trial
Hanneke C. Kluin‐Nelemans(University Medical Center Groningen), Martin Dreyling(LMU Klinikum), Stephan Stilgenbauer(Universität Ulm), Christian Schmidt(Ludwig-Maximilians-Universität München), Vincent Ribrag(Institut Gustave Roussy), Catherine Thiéblemont(Université Paris Cité), Eva Hoster(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Jan Walewski(The Maria Sklodowska-Curie National Research Institute of Oncology), Michał Szymczyk(The Maria Sklodowska-Curie National Research Institute of Oncology), Olivier Hermine(Centre National de la Recherche Scientifique), Josée M. Zijlstra(Amsterdam University Medical Centers), Florian Kaiser(University of Applied Sciences Landshut), Gilles Salles(Memorial Sloan Kettering Cancer Center), Marek Trněný(Charles University), Christian H. Geisler(Copenhagen University Hospital), Wolfgang Hiddemann(Christian-Albrechts-Universität zu Kiel), Lothar Kanz(University of Freiburg), Pierre Feugier(Centre Hospitalier Régional et Universitaire de Nancy), Michael Unterhalt, Hervé Tilly(Centre Virchow-Villermé), Christiane Pott(University Hospital Schleswig-Holstein), Jeanette K. Doorduijn(Erasmus MC Cancer Institute)
Cited by 143
Related Papers
iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL
|Blood|2018|1.7k
Idelalisib and Rituximab in Relapsed Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2014|1.7k
The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee
|Blood|2022|1.5k
A Biologic Definition of Burkitt's Lymphoma from Transcriptional and Genomic Profiling
|New England Journal of Medicine|2006|1k